361 related articles for article (PubMed ID: 12833122)
1. Gene therapy progress and prospects: adenoviral vectors.
St George JA
Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral vectors for gene transfer and therapy.
Volpers C; Kochanek S
J Gene Med; 2004 Feb; 6 Suppl 1():S164-71. PubMed ID: 14978759
[TBL] [Abstract][Full Text] [Related]
3. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
4. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
Kügler S; Kilic E; Bähr M
Gene Ther; 2003 Feb; 10(4):337-47. PubMed ID: 12595892
[TBL] [Abstract][Full Text] [Related]
5. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
Bilbao R; Reay DP; Wu E; Zheng H; Biermann V; Kochanek S; Clemens PR
Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668
[TBL] [Abstract][Full Text] [Related]
6. Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates.
Butti E; Bergami A; Recchia A; Brambilla E; Franciotta D; Cattalini A; Stornaiuolo A; Lachapelle F; Comi G; Mavilio F; Martino G; Furlan R
Gene Ther; 2008 Feb; 15(3):233-8. PubMed ID: 17960158
[TBL] [Abstract][Full Text] [Related]
7. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
8. Approaches to improving the kinetics of adenovirus-delivered genes and gene products.
Xu ZL; Mizuguchi H; Sakurai F; Koizumi N; Hosono T; Kawabata K; Watanabe Y; Yamaguchi T; Hayakawa T
Adv Drug Deliv Rev; 2005 Apr; 57(5):781-802. PubMed ID: 15757761
[TBL] [Abstract][Full Text] [Related]
9. Use of multiply deleted adenovirus vectors to probe adenovirus vector performance and toxicities.
Amalfitano A
Curr Opin Mol Ther; 2003 Aug; 5(4):362-6. PubMed ID: 14513678
[TBL] [Abstract][Full Text] [Related]
10. A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors.
Reynolds PN; Holmes MD; Adachi Y; Kaliberova L; Curiel DT
Gene Ther; 2001 Aug; 8(16):1271-5. PubMed ID: 11509961
[TBL] [Abstract][Full Text] [Related]
11. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.
Hoganson DK; Sosnowski BA; Pierce GF; Doukas J
Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
13. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
14. Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications.
Parker AL; Nicklin SA; Baker AH
Curr Opin Mol Ther; 2008 Oct; 10(5):439-48. PubMed ID: 18830919
[TBL] [Abstract][Full Text] [Related]
15. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
16. High-capacity 'gutless' adenoviral vectors.
Kochanek S; Schiedner G; Volpers C
Curr Opin Mol Ther; 2001 Oct; 3(5):454-63. PubMed ID: 11699889
[TBL] [Abstract][Full Text] [Related]
17. Development of PEGylated adenovirus vector with targeting ligand.
Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
[TBL] [Abstract][Full Text] [Related]
19. The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector.
Mizuguchi H; Hayakawa T
J Gene Med; 2002; 4(3):240-7. PubMed ID: 12112641
[TBL] [Abstract][Full Text] [Related]
20. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
